David J. Taber

Title
InstitutionMedical University of South Carolina
DepartmentSurgery
AddressP.O. Box MSC 613
CSB 409
96 Jonathan Lucas St.
Phone843-792-2724
Fax843-792-8596
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Cardiovascular, Kidney, Transplant

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Taber DJ, Hirsch J, Keys A, Su Z, McGillicuddy JW. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients. Ther Drug Monit. 2021 06 01; 43(3):401-407. PMID: 33560095.
      Citations:    
    2. DuBay DA, Morinelli TA, Su Z, Mauldin P, Weeda E, Casey MJ, Baliga P, Taber DJ. Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 May 26. PMID: 34037705.
      Citations:    
    3. Stoll WD, Mester RA, Fleming JN, Sirianni JM, Abro JA, Colhoun ED, Taber DJ, Hebbar L. Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation. Transplant Proc. 2021 May 18. PMID: 34020795.
      Citations:    
    4. Mohamed MM, Soliman KM, Pullalarevu R, Kamel M, Srinivas T, Taber DJ, Salas M. Non-adherence to Appointments is a Strong Predictor of Medication Non-Adherence and Outcomes in Kidney Transplant Recipients. Am J Med Sci. 2021 May 17. PMID: 34015328.
      Citations:    
    5. Patel N, Perez C, Taber DJ, Kalbavi V, Gonzales H, Rohan V. Safety and Efficacy of Perioperative Sublingual Tacrolimus in Pancreas Transplant Compared With Oral Tacrolimus. Exp Clin Transplant. 2021 Jun; 19(6):592-595. PMID: 33952179.
      Citations:    
    6. Gonzales HM, Fleming JN, Gebregziabher M, Posadas-Salas MA, Su Z, McGillicuddy JW, Taber DJ. Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 May 08; 16(5):776-784. PMID: 33931415.
      Citations:    
    7. Fleming JN, Gebregziabher M, Posadas A, Su Z, McGillicuddy JW, Taber DJ. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 Apr 04. PMID: 33821958.
      Citations:    
    8. Rabon AD, Taber DJ, Uber WE, Houston BA, Meadows H. Unfractionated and Low-Molecular-Weight Heparin for Bridging Patients with Left Ventricular Assist Device: An Event-Based Analysis. ASAIO J. 2021 Mar 17. PMID: 33741791.
      Citations:    
    9. Salas MAP, Rodriguez-Abreu RD, Amaechi P, Rao V, Soliman K, Taber D. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 Feb 25. PMID: 33640364.
      Citations:    
    10. Basco WT, Ward RC, Taber DJ, Simpson KN, Gebregziabher M, Cina RA, McCauley JL, Lockett MA, Moran WP, Mauldin PD, Ball SJ. Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636. PMID: 33548590.
      Citations:    
    11. Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy. 2021 01; 41(1):119-131. PMID: 33131123.
      Citations:    
    12. Chung CW, Kalbavi V, Siegel JB, Taber DJ, Rohan V. Music Therapy in Dialysis Access Procedures With Moderate Sedation. Am Surg. 2020 Dec 28; 3134820973383. PMID: 33371722.
      Citations:    
    13. Lockett MA, Mauldin PD, Zhang J, Marsden JE, Taber DJ, Gebregziabher M, Chung C, Hebbar P, Adams L, Baliga PK. Facilitated Regional Collaboration and In-Hospital Surgical Complication. J Am Coll Surg. 2021 Apr; 232(4):536-543. PMID: 33383216.
      Citations:    
    14. Rohan VS, Pilch N, Cassidy D, McGillicuddy J, White J, Lin A, Nadig SN, Taber DJ, Dubay D, Baliga PK. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449. PMID: 33359232.
      Citations:    
    15. Wise B, Wilson LZ, Taber DJ, Pilch NA, Rohan V, Fleming JN. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13. PMID: 33107627.
      Citations:    
    16. Weeda ER, Bishu KG, Ward R, Axon RN, Taber DJ, Gebregziabher M. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449. PMID: 33059602.
      Citations:    
    17. Rohan VS, Taber DJ, Patel N, Perez C, Pilch N, Parks S, Bolin E, Nadig SN, Baliga PK, Fleming JN. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006. PMID: 32524643.
      Citations:    
    18. Ward R, Weeda ER, Bishu KG, Axon RN, Taber DJ, Gebregziabher M. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098. PMID: 32857659.
      Citations:    
    19. Posadas Salas MA, Taber D, Soliman K, Nwadike E, Srinivas T. Phenotype of immunosuppression reduction after kidney transplantation. Clin Transplant. 2020 10; 34(10):e14047. PMID: 32686181.
      Citations:    
    20. Perkins H, Taber D, Patel N, Rohan V, Su Z, Dubay D, McGillicuddy J. Patterns of emergency department utilization between transplant and non-transplant centers and impact on clinical outcomes in kidney recipients. Clin Transplant. 2020 09; 34(9):e13983. PMID: 32639652.
      Citations:    
    21. Gonzales HM, McGillicuddy JW, Rohan V, Chandler JL, Nadig SN, Dubay DA, Taber DJ. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am J Transplant. 2020 08; 20(8):1969-1983. PMID: 32406604.
      Citations:    
    22. McGillicuddy JW, Chandler JL, Sox LR, Taber DJ. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. Ann Pharmacother. 2020 12; 54(12):1185-1193. PMID: 32506922.
      Citations:    
    23. Fleming JN, Posadas Salas MA, Taber DJ. Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS). Ther Drug Monit. 2020 06; 42(3):415-420. PMID: 31913864.
      Citations:    
    24. Taber DJ, Posadas-Salas A, Su Z, Rao V, Rohan V, Nadig S, McGillicuddy JW, Dubay D, Fleming JN. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clin Transplant. 2020 04; 34(4):e13844. PMID: 32092187.
      Citations:    
    25. Weeda ER, Bishu KG, Ward RC, Brown EA, Axon RN, Taber DJ, Gebregziabher M. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499. PMID: 32245632.
      Citations:    
    26. Fleming JN, Zhang J, Taber DJ, McCauley JL, Schumann S, Mauldin PD, Ball S. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):559-564. PMID: 32033899.
      Citations:    
    27. Rohan VS, Pilch N, Moussa O, Nadig SN, Dubay D, Baliga PK, Taber DJ. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379. PMID: 32035182.
      Citations:    
    28. Weeda ER, Su Z, Taber DJ, Bian J, Morinelli TA, Casey M, DuBay DA. Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort study. Transpl Int. 2020 04; 33(4):414-422. PMID: 31930584.
      Citations:    
    29. Chiasson JM, Fominaya CE, Gebregziabher M, Taber DJ. Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients. Transplantation. 2019 12; 103(12):2675-2681. PMID: 30830038.
      Citations:    
    30. Hall CL, Fominaya CE, Gebregziabher M, Milfred-LaForest SK, Rife KM, Taber DJ. Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2019 Oct 01; 8(10):e13821. PMID: 31573933.
      Citations:    
    31. Brown EA, Ward RC, Weeda E, Taber DJ, Axon RN, Gebregziabher M. Racial-Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study. Health Equity. 2019; 3(1):472-479. PMID: 31576377.
      Citations:    
    32. Elmaasarani Z, Mardis C, Gylten L, Taber DJ, Fleming J, Patel N, Baliga P, Rao V, Rohan V, DuBay D, Pilch NA. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701. PMID: 31461791.
      Citations:    
    33. Taber DJ, Chokkalingam A, Su Z, Self S, Miller D, Srinivas T. Randomized controlled trial assessing the impact of everolimus and low-exposure tacrolimus on graft outcomes in kidney transplant recipients. Clin Transplant. 2019 10; 33(10):e13679. PMID: 31365151.
      Citations:    
    34. Rohan VS, McGillicuddy JW, Taber DJ, Nadig SN, Baliga PK, Bratton CF. Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clin Transplant. 2019 10; 33(10):e13695. PMID: 31421062.
      Citations:    
    35. Shenvi SD, Taber DJ, Hardie AD, Botstein JO, McGillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020 01; 22(1):102-108. PMID: 31405777.
      Citations:    
    36. Taber DJ, Pilch NA, McGillicuddy JW, Mardis C, Treiber F, Fleming JN. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149. PMID: 31361870.
      Citations:    
    37. Ozieh MN, Gebregziabher M, Ward RC, Taber DJ, Egede LE. Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease. BMC Nephrol. 2019 07 03; 20(1):241. PMID: 31269903.
      Citations:    
    38. DuBay DA, Su Z, Morinelli TA, Baliga P, Rohan V, Bian J, Northrup D, Pilch N, Rao V, Srinivas TR, Mauldin PD, Taber DJ. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862. PMID: 30198104.
      Citations:    
    39. Converse MP, Sobhanian M, Taber DJ, Houston BA, Meadows HB, Uber WE. Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778. PMID: 30975293.
      Citations:    
    40. Weeda ER, Su Z, Taber DJ, Bian J, Morinelli TA, Pilch NA, Mauldin PD, DuBay DA. Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522. PMID: 30861180.
      Citations:    
    41. Taber DJ, Ward R, Axon RN, Walker RJ, Egede LE, Gebregziabher M. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682. PMID: 30724092.
      Citations:    
    42. Nichols TA, Robert S, Taber DJ, Cluver J. Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility. Ment Health Clin. 2019 Jan; 9(1):1-5. PMID: 30627496.
      Citations:    
    43. Soliman KM, Posadas Salas AC, Taber DJ. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Exp Clin Transplant. 2019 12; 17(6):707-713. PMID: 30570456.
      Citations:    
    44. Rohan V, Taber D, Palanisamy A, Mcgillicuddy J, Chavin K, Baliga P, Bratton C. Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. Exp Clin Transplant. 2019 12; 17(6):796-802. PMID: 30501589.
      Citations:    
    45. Dismuke-Greer CE, Gebregziabher M, Byers AL, Taber D, Axon N, Yaffe K, Egede LE. Comorbid TBI-depression costs in veterans: a chronic effect of neurotrauma consortium (CENC) study. Brain Inj. 2018 Nov 07; 1-7. PMID: 30403538.
      Citations:    
    46. Ward RC, Taber DJ, Axon RN, Gebregziabher M. Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094. PMID: 30144128.
      Citations:    
    47. Taber DJ, Su Z, Fleming JN, Pilch NA, Morinelli T, Mauldin P, Dubay D. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94. PMID: 30176087.
      Citations:    
    48. Perez CP, Patel N, Mardis CR, Meadows HB, Taber DJ, Pilch NA. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types. Transplantation. 2018 09; 102(9):1440-1452. PMID: 29787522.
      Citations:    
    49. Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371. PMID: 29856528.
      Citations:    
    50. Gebregziabher M, Ward RC, Taber DJ, Walker RJ, Ozieh M, Dismuke CE, Axon RN, Egede LE. Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts. Soc Sci Med. 2018 08; 211:198-206. PMID: 29960171.
      Citations:    
    51. Taber DJ, Gebregziabher M, Posadas A, Schaffner C, Egede LE, Baliga PK. Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients. J Am Coll Clin Pharm. 2018 Dec; 1(2):81-88. PMID: 30714026.
      Citations:    
    52. Sieverdes JC, Rao V, Taber DJ, Noltemeyer Z, McGillicuddy JW, Bergamin M, Thangavel S, Baliga PK. Feasibility and Functional Testing for Frailty in Chronic Kidney Disease. Prog Transplant. 2018 09; 28(3):299-300. PMID: 29898640.
      Citations:    
    53. Fleming JN, Taber DJ, Axelrod D, Chavin KD. The effect of Share 35 on biliary complications: An interrupted time series analysis. Am J Transplant. 2019 01; 19(1):221-226. PMID: 29767478.
      Citations:    
    54. Simpson KN, Seamon BA, Hand BN, Roldan CO, Taber DJ, Moran WP, Simpson AN. Effect of frailty on resource use and cost for Medicare patients. J Comp Eff Res. 2018 08; 7(8):817-825. PMID: 29808714.
      Citations:    
    55. Avery LM, Fominaya CE, Crawford RC, Pleasants KP, Taber DJ. Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population. Ann Pharmacother. 2018 10; 52(10):974-982. PMID: 29770702.
      Citations:    
    56. Sanchez D, Dubay D, Prabhakar B, Taber DJ. Evolving Trends in Racial Disparities for Peri-Operative Outcomes with the New Kidney Allocation System (KAS) Implementation. J Racial Ethn Health Disparities. 2018 12; 5(6):1171-1179. PMID: 29557046.
      Citations:    
    57. Pilch NA, Rohan V, Rao V, Mauldin PD, Su Z, Dubay DA, Morinelli TA, Taber DJ. Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. Am J Nephrol. 2018; 47(3):191-199. PMID: 29539601.
      Citations:    
    58. Fleming JN, Treiber F, McGillicuddy J, Gebregziabher M, Taber DJ. Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR Res Protoc. 2018 Mar 02; 7(3):e59. PMID: 29500161.
      Citations:    
    59. Taber DJ, Gebregziabher M, Srinivas T, Egede LE, Baliga PK. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128. PMID: 29449524.
      Citations:    
    60. Vranian SC, Covert KL, Mardis CR, McGillicuddy JW, Chavin KD, Dubay D, Taber DJ. Assessment of risk factors for increased resource utilization in kidney transplantation. J Surg Res. 2018 02; 222:195-202.e2. PMID: 29100587.
      Citations:    
    61. Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659. PMID: 29309943.
      Citations:    
    62. Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938. PMID: 28658199.
      Citations:    
    63. Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6). PMID: 28921781.
      Citations:    
    64. Cole AJ, Johnson RW, Egede LE, Baliga PK, Taber DJ. Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods. Contemp Clin Trials Commun. 2018 Mar; 9:1-6. PMID: 29532038.
      Citations:    
    65. Arms MA, Fleming J, Sangani DB, Nadig SN, McGillicuddy JW, Taber DJ. Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients. Surgery. 2018 02; 163(2):430-435. PMID: 29174434.
      Citations:    
    66. Thrall SA, Fominaya CE, Chiasson JM, Castle S, Taber DJ. Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017 Sep 01; 74(17 Supplement 3):S67-S74. PMID: 28842520.
      Citations:    
    67. Taber DJ, McGillicuddy JW, Bratton CF, Rohan VS, Nadig S, Dubay D, Baliga PK. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456. PMID: 28654544.
      Citations:    
    68. Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668. PMID: 28622834.
      Citations:    
    69. Thrall SA, Egede LE, Taber DJ. Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients. Prog Transplant. 2017 06; 27(2):187-191. PMID: 28617159.
      Citations:    
    70. Fleming JN, Taber DJ, McElligott J, McGillicuddy JW, Treiber F. Mobile Health in Solid Organ Transplant: The Time Is Now. Am J Transplant. 2017 Sep; 17(9):2263-2276. PMID: 28188681.
      Citations:    
    71. Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169. PMID: 27997676.
      Citations:    
    72. Taber DJ, Gebregziabher M, Payne EH, Srinivas T, Baliga PK, Egede LE. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410. PMID: 26901080.
      Citations:    
    73. Taber DJ, DuBay D, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592. PMID: 28159650.
      Citations:    
    74. Srinivas TR, Taber DJ, Su Z, Zhang J, Mour G, Northrup D, Tripathi A, Marsden JE, Moran WP, Mauldin PD. Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept. Am J Transplant. 2017 03; 17(3):671-681. PMID: 27804279.
      Citations:    
    75. Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA. Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. World J Transplant. 2016 Dec 24; 6(4):697-702. PMID: 28058220.
      Citations:    
    76. Taber DJ, Hunt KJ, Gebregziabher M, Srinivas T, Chavin KD, Baliga PK, Egede LE. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139. PMID: 27979979.
      Citations:    
    77. Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98. PMID: 27907919.
      Citations:    
    78. Taber DJ, Egede LE, Baliga PK. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672. PMID: 27887677.
      Citations:    
    79. Colhoun ED, Forsberg CG, Chavin KD, Baliga PK, Taber DJ. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836. PMID: 27771158.
      Citations:    
    80. Taber DJ, Gebregziabher M, Hunt KJ, Srinivas T, Chavin KD, Baliga PK, Egede LE. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87. PMID: 27555121.
      Citations:    
    81. Rodrigue JR, Schold JD, Mandelbrot DA, Taber DJ, Phan V, Baliga PK. Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors. Prog Transplant. 2016 Dec; 26(4):292-298. PMID: 27495327.
      Citations:    
    82. Fleming JN, Taber DJ, Pilch NA, Srinivas TR, Chavin KD. Yes, We Still Need IL-2 Receptor Antagonists. Am J Transplant. 2016 11; 16(11):3308-3309. PMID: 27321737.
      Citations:    
    83. Taber DJ, Hunt KJ, Fominaya CE, Payne EH, Gebregziabher M, Srinivas TR, Baliga PK, Egede LE. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25. PMID: 27402921.
      Citations:    
    84. Browning RB, McGillicuddy JW, Treiber FA, Taber DJ. Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapy. J Am Pharm Assoc (2003). 2016 Jul-Aug; 56(4):450-454.e1. PMID: 27450140.
      Citations:    
    85. Taber DJ, Hamedi M, Rodrigue JR, Gebregziabher MG, Srinivas TR, Baliga PK, Egede LE. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7. PMID: 26425875.
      Citations:    
    86. Sebaaly JC, Fleming J, Pilch N, Meadows H, Finn A, Chavin K, Baliga P, Bratton CF, McGillicuddy JW, Nadig S, Taber D. Depression, Resource Utilization, and Outcomes Following Liver Transplant. Prog Transplant. 2016 Sep; 26(3):270-6. PMID: 27297232.
      Citations:    
    87. Rohan VS, Taber DJ, Moussa O, Pilch NA, Denmark S, Meadows HB, McGillicuddy JW, Chavin KD, Baliga PK, Bratton CF. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55. PMID: 27267614.
      Citations:    
    88. Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86. PMID: 27101090.
      Citations:    
    89. Stoll WD, Taber DJ, Palesch SJ, Hebbar L. Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population? Prog Transplant. 2016 Jun; 26(2):122-8. PMID: 27207400.
      Citations:    
    90. Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33. PMID: 26914542.
      Citations:    
    91. Ozieh MN, Taber DJ, Egede LE. Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes? Medicine (Baltimore). 2015 Dec; 94(49):e2283. PMID: 26656377.
      Citations:    
    92. Jordan CL, Taber DJ, Kyle MO, Connelly J, Pilch NW, Fleming J, Meadows HB, Bratton CF, Nadig SN, McGillicuddy JW, Chavin KD, Baliga PK, Shatat IF, Twombley K. Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8. PMID: 26576516.
      Citations:    
    93. Staino C, Pilch N, Patel S, Trobaugh K, Fleming J, Meadows H, Taber D, Srinivas TR, Baliga P. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620. PMID: 26547595.
      Citations:    
    94. McGillicuddy JW, Taber DJ, Mueller M, Patel S, Baliga PK, Chavin KD, Sox L, Favela AP, Brunner-Jackson BM, Treiber FA. Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23. PMID: 26308780.
      Citations:    
    95. Palanisamy AP, Dowden JE, Al Manasra AR, Rohan VS, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ. Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation? Prog Transplant. 2015 Sep; 25(3):257-62. PMID: 26308786.
      Citations:    
    96. Taber DJ, Gebregziabher MG, Srinivas TR, Chavin KD, Baliga PK, Egede LE. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77. PMID: 26011276.
      Citations:    
    97. Taber DJ, Pilch NA, Trofe-Clark J, Kaiser TE. A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs. Am J Transplant. 2015 Oct; 15(10):2683-90. PMID: 25988533.
      Citations:    
    98. Connelly J, Pilch N, Oliver M, Jordan C, Fleming J, Meadows H, Baliga P, Nadig S, Twombley K, Shatat I, Taber D. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62. PMID: 25917112.
      Citations:    
    99. Trofe-Clark J, Kaiser T, Pilch N, Taber D. Value of solid organ transplant-trained pharmacists in transplant infectious diseases. Curr Infect Dis Rep. 2015 Apr; 17(4):475. PMID: 25870143.
      Citations:    
    100. Hand WR, Whiteley JR, Epperson TI, Tam L, Crego H, Wolf B, Chavin KD, Taber DJ. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg. 2015 Mar; 120(3):619-26. PMID: 25036375.
      Citations:    
    101. Taber DJ, Palanisamy AP, Srinivas TR, Gebregziabher M, Odeghe J, Chavin KD, Egede LE, Baliga PK. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30. PMID: 25594549.
      Citations:    
    102. Palanisamy AP, Al Manasra AR, Pilch NA, Dowden JE, Nadig SN, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015 Mar; 29(3):222-6. PMID: 25557762.
      Citations:    
    103. McGillicuddy JW, Villar JJ, Rohan VS, Bazaz S, Taber DJ, Pilch NA, Baliga PK, Chavin KD. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5. PMID: 25569066.
      Citations:    
    104. Palanisamy AP, Taber DJ, Sutter AG, Nadig SN, Dowden JE, McGillicuddy JW, Baliga PK, Chavin KD. Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis. J Gastrointest Surg. 2015 Feb; 19(2):282-9. PMID: 25319035.
      Citations:    
    105. Li P, Hunt KJ, Taber DJ, Carter RE, Kettinger L, Luttrell D, Egidi MF, Finch NJ, Baliga P, Lin A, Biggins S, Hermayer KL. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9. PMID: 24831919.
      Citations:    
    106. Byrns JS, Pilch NW, Taber DJ. Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation. J Pharm Pract. 2016 Apr; 29(2):97-102. PMID: 25107422.
      Citations:    
    107. Palanisamy AP, Schiltz CE, Pilch NA, Hunt KJ, Nadig SN, Dowden JE, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22. PMID: 25048253.
      Citations:    
    108. Taber DJ, Douglass K, Srinivas T, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK, Egede LE. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28. PMID: 24969370.
      Citations:    
    109. Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8. PMID: 24893750.
      Citations:    
    110. Wiggins BS, Nappi J, Fortier CR, Taber DJ. Cardiovascular Drug Shortages: Predominant Etiologies, Clinical Implications, and Management Strategies. Ann Pharmacother. 2014 Sep; 48(9):1177-1186. PMID: 24915735.
      Citations:    
    111. Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93. PMID: 24513787.
      Citations:    
    112. Tichy EM, Pilch NA, Smith LD, Maldonado AQ, Taber DJ. Building a business plan to support a transplantation pharmacy practice model. Am J Health Syst Pharm. 2014 May 01; 71(9):751-7. PMID: 24733139.
      Citations:    
    113. Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6. PMID: 24763866.
      Citations:    
    114. Scheffert JL, Taber DJ, Pilch NA, Chavin KD, Baliga PK, Bratton CF. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5. PMID: 24285337.
      Citations:    
    115. Nichols TA, Drayton SJ, Borckardt J, Taber DJ. Lithium dosing equations: are they accurate? Ann Pharmacother. 2014 May; 48(5):596-600. PMID: 24577145.
      Citations:    
    116. Srinivas R, Chavin KD, Baliga PK, Srinivas T, Taber DJ. Association between patient satisfaction and outcomes in kidney transplant. Am J Med Qual. 2015 Mar-Apr; 30(2):180-5. PMID: 24463328.
      Citations:    
    117. Taber DJ, McGillicuddy JW, Bratton CF, Lin A, Chavin KD, Baliga PK. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97. PMID: 24491243.
      Citations:    
    118. Taber DJ, Belk L, Meadows H, Pilch N, Fleming J, Srinivas T, McGillicuddy J, Bratton C, Chavin K, Baliga P. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9. PMID: 24061443.
      Citations:    
    119. Hassig TB, McKinzie BP, Fortier CR, Taber D. Clinical management strategies and implications for parenteral nutrition drug shortages in adult patients. Pharmacotherapy. 2014 Jan; 34(1):72-84. PMID: 24399661.
      Citations:    
    120. Thomas B, Taber DJ, Srinivas TR. Hypertension after kidney transplantation: a pathophysiologic approach. Curr Hypertens Rep. 2013 Oct; 15(5):458-69. PMID: 23933793.
      Citations:    
    121. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91. PMID: 24061145.
      Citations:    
    122. Posadas Salas MA, Taber DJ, Chua E, Pilch N, Chavin K, Thomas B. Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation. Transpl Infect Dis. 2013 Dec; 15(6):551-8. PMID: 24010993.
      Citations:    
    123. McGillicuddy JW, Gregoski MJ, Weiland AK, Rock RA, Brunner-Jackson BM, Patel SK, Thomas BS, Taber DJ, Chavin KD, Baliga PK, Treiber FA. Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial. JMIR Res Protoc. 2013 Sep 04; 2(2):e32. PMID: 24004517.
      Citations:    
    124. Chavin KD, Taber DJ, Norcross M, Pilch NA, Crego H, McGillicuddy JW, Bratton CF, Lin A, Baliga PK. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013 Sep-Oct; 27(5):732-41. PMID: 23991646.
      Citations:    
    125. Scheffert JL, Taber DJ, Pilch NA, McGillicuddy JW, Baliga PK, Chavin KD. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013 May; 33(5):483-8. PMID: 23468226.
      Citations:    
    126. McGillicuddy JW, Taber DJ, Pilch NA, Kohout RK, Bratton CF, Chavin KD, Baliga PK. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8. PMID: 23448818.
      Citations:    
    127. Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82. PMID: 23383719.
      Citations:    
    128. Taber DJ, Pilch NA, McGillicuddy JW, Bratton CF, Lin A, Chavin KD, Baliga PK. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8. PMID: 23391592.
      Citations:    
    129. Musgrave CR, Pilch NA, Taber DJ, Meadows HB, McGillicuddy JW, Chavin KD, Baliga PK. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801. PMID: 23332093.
      Citations:    
    130. McGillicuddy JW, Weiland AK, Frenzel RM, Mueller M, Brunner-Jackson BM, Taber DJ, Baliga PK, Treiber FA. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res. 2013 Jan 08; 15(1):e6. PMID: 23305649.
      Citations:    
    131. Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44. PMID: 23530307.
      Citations:    
    132. Taber DJ, Pilch NA, Meadows HB, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK, Egede LE. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50. PMID: 23258931.
      Citations:    
    133. Taber DJ, Pilch NA, Bratton CF, McGillicuddy JW, Chavin KD, Baliga PK. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60. PMID: 23165887.
      Citations:    
    134. Cooper T, White CL, Taber D, Uber WE, Kokko H, Mazur J. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Am J Health Syst Pharm. 2012 Nov 15; 69(22):1993-8. PMID: 23135566.
      Citations:    
    135. Krisl JC, Fortier CR, Taber DJ. Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician. Am J Transplant. 2013 Jan; 13(1):20-30. PMID: 23126622.
      Citations:    
    136. Riggs H, Jalal SI, Baghdadi TA, Bhatia S, McClean J, Johnson C, Yu M, Taber D, Harb W, Hanna N. Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer. 2013 May; 14(3):224-9. PMID: 23102811.
      Citations:    
    137. Shay R, Taber D, Pilch N, Meadows H, Tischer S, McGillicuddy J, Bratton C, Baliga P, Chavin K. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):330-4. PMID: 23267805.
      Citations:    
    138. Taber DJ, Pilch NA, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12. PMID: 22822171.
      Citations:    
    139. Shatat IF, Taber DJ, Shrivastava S, Weimert NA, Sas DJ, Chavin KD, Orak JK, Baliga PK. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92. PMID: 22805378.
      Citations:    
    140. Meadows HB, Taber DJ, Pilch NA, Tischer SM, Baliga PK, Chavin KD. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Transplant Proc. 2012 Jun; 44(5):1323-8. PMID: 22664009.
      Citations:    
    141. Hulbert AL, Pilch NA, Taber DJ, Chavin KD, Baliga PK. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7. PMID: 22570436.
      Citations:    
    142. Krisl JC, Taber DJ, Pilch N, Chavin K, Bratton C, Thomas B, McGillicuddy J, Baliga P. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9. PMID: 22461534.
      Citations:    
    143. Alloway RR, Dupuis R, Gabardi S, Kaiser TE, Taber DJ, Tichy EM, Weimert-Pilch NA. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant. 2011 Aug; 11(8):1576-83. PMID: 21672154.
      Citations:    
    144. Jensen CJ, Shrivastava S, Taber DJ, Weimert NA, Shatat IF, Orak J, Chavin KD, Baliga PK. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40. PMID: 20636410.
      Citations:    
    145. Dunn BL, Teusink AC, Taber DJ, Hemstreet BA, Uber LA, Weimert NA. Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies. Ann Pharmacother. 2010 Jul-Aug; 44(7-8):1259-70. PMID: 20587745.
      Citations:    
    146. McGillicuddy JW, Weimert NA, Taber DJ, Turner A, Mitchell LA, Wray DW, Egidi MF, Kuppachi S, Hughes MG, Baliga PK, Chavin KD. Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? Transplantation. 2010 May 27; 89(10):1218-23. PMID: 20410854.
      Citations:    
    147. Patel N, Taber DJ, Weimert NA, Fleming JN, Egidi FM, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7. PMID: 20005354.
      Citations:    
    148. Fleming JN, Taber DJ, Weimert NA, Egidi MF, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5. PMID: 19951304.
      Citations:    
    149. Cooper T, Taber D, Mazur J. Implementation of a collaborative drug therapy management service for inpatients receiving direct thrombin inhibitors. Am J Health Syst Pharm. 2009 Jul 15; 66(14):1297-303. PMID: 19574605.
      Citations:    
    150. Berkman S, Weimert NA, Taber DJ, Baillie GM, Lin A, Baliga P, Chavin KD. The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series. Transpl Infect Dis. 2009 Jun; 11(3):269-76. PMID: 19392728.
      Citations:    
    151. Taber DJ, Ashcraft E, Cattanach LA, Baillie GM, Weimert NA, Lin A, Bratton CF, Baliga PK, Chavin KD. No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech. 2009 Apr; 19(2):153-6. PMID: 19390284.
      Citations:    
    152. Hammond EB, Taber DJ, Weimert NA, Egidi MF, Bratton CF, Lin A, McGillicuddy JW, Chavin KD, Baliga PK. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7. PMID: 19236436.
      Citations:    
    153. Taber DJ, Weimert NA, Henderson F, Lin A, Bratton CF, Chavin KD, Baliga PK. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7. PMID: 19100399.
      Citations:    
    154. Agarwala A, Fisher W, Bruetman D, McClean J, Taber D, Titzer M, Juliar B, Yu M, Breen T, Einhorn LH, Hanna N. Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group. J Thorac Oncol. 2008 Apr; 3(4):374-9. PMID: 18379355.
      Citations:    
    155. Jennings DL, Taber DJ. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother. 2008 Jan; 42(1):116-20. PMID: 18094340.
      Citations:    
    156. Taber DJ, Ashcraft EA, Baillie GM, Lawrence DB, Chavin KD, Baliga PK. Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50. PMID: 17456539.
      Citations:    
    157. Taber DJ, Baillie GM, Ashcraft EE, Rogers J, Lin A, Afzal F, Baliga P, Rajagopalan PR, Chavin KD. Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5. PMID: 16371936.
      Citations:    
    158. Desai AA, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, Vokes EE. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer. Cancer Chemother Pharmacol. 2005 Oct; 56(4):421-6. PMID: 15895230.
      Citations:    
    159. Taber DJ, Ashcraft E, Baillie GM, Berkman S, Rogers J, Baliga PK, Rajagopalan PR, Lin A, Emovon O, Afzal F, Chavin KD. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9. PMID: 15569225.
      Citations:    
    160. Rogers J, Ashcraft EE, Emovon OE, Baillie GM, Taber DJ, Marques RG, Baliga PK, Chavin KD, Lin A, Afzal F, Rajagopalan PR. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22. PMID: 15446324.
      Citations:    
    161. Marques RG, Rogers J, Chavin KD, Baliga PK, Lin A, Emovon O, Afzal F, Baillie GM, Taber DJ, Ashcraft EE, Rajagopalan PR. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May; 36(4):1048-9. PMID: 15194364.
      Citations:    
    162. Rogers J, Ashcraft EE, Baliga PK, Chavin KD, Lin A, Emovon O, Afzal F, Baillie GM, Taber DJ, Alvarez S, Pullatt RC, Rajagopalan PR. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1058-60. PMID: 15194367.
      Citations:    
    163. Rogers J, Chavin KD, Baliga PK, Lin A, Emovon O, Afzal F, Ashcraft EE, Baillie GM, Taber DJ, Rajagopalan PR. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101. PMID: 14675721.
      Citations:    
    164. Taber DJ, Fann AL, Malat G, Dupuis RE. Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients. Ther Drug Monit. 2003 Feb; 25(1):67-72. PMID: 12548147.
      Citations:    
    165. Taber DJ, Dupuis RE, Fann AL, Andreoni KA, Gerber DA, Fair JH, Johnson MW, Shrestha R. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. Liver Transpl. 2002 Mar; 8(3):219-23. PMID: 11910566.
      Citations:    
    166. Sadiq TS, Burns WW, Taber DJ, Damitz L, Ollila DW. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg. 2001 Dec; 136(12):1433-5. PMID: 11735875.
      Citations:    
    167. Taber DJ, Dupuis RE, Hollar KD, Strzalka AL, Johnson MW. Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. Transplant Proc. 2000 May; 32(3):660-2. PMID: 10812156.
      Citations:    
    168. Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol. 2000 Jan; 18(2):371-5. PMID: 10637252.
      Citations:    
    169. Vogelzang NJ, Mani S, Schilsky RL, Ansari RH, Taber D, Rhinehart SN, Garcia JC, Meyer SC, Mick R, Brockstein BE, Stadler WM, Ratain MJ, Vokes EE. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. Clin Cancer Res. 1998 Apr; 4(4):929-34. PMID: 9563886.
      Citations:    
    Taber's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (441)
    Explore
    _
    Co-Authors (67)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _